Global Multiple Myeloma Therapeutics Market Size, Status and Forecast 2022

January 2017 | 117 pages | ID: G5957915FC0EN
QYResearch

Abstracts

Notes:

Production, means the output of Multiple Myeloma Therapeutics

Revenue, means the sales value of Multiple Myeloma Therapeutics

This report studies the global Multiple Myeloma Therapeutics market, analyzes and researches the Multiple Myeloma Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

• Janssen Biotech, Inc.
• Bristol-Myers Squibb
• Novartis AG
• Bristol-Myers Squibb Company
• Millennium Pharmaceuticals
• Celgene Corporation
• Kesios Therapeutics Limited
• Amgene, Inc.
• Genzyme Corporation
• Juno Therapeutics

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, Multiple Myeloma Therapeutics can be split into

• Chemotherapy And Other Drugs
• Radiation
• Stem Cell Transplant
• Other Supportive Treatments

Market segment by Application, Multiple Myeloma Therapeutics can be split into

• Hospitals
• Clinics
• Others

Contents

Global Multiple Myeloma Therapeutics Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF MULTIPLE MYELOMA THERAPEUTICS

1.1 Multiple Myeloma Therapeutics Market Overview
  1.1.1 Multiple Myeloma Therapeutics Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Multiple Myeloma Therapeutics Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Multiple Myeloma Therapeutics Market by Type
  1.3.1 Chemotherapy And Other Drugs
  1.3.2 Radiation
  1.3.3 Stem Cell Transplant
  1.3.4 Other Supportive Treatments
1.4 Multiple Myeloma Therapeutics Market by End Users/Application
  1.4.1 Hospitals
  1.4.2 Clinics
  1.4.3 Others

2 GLOBAL MULTIPLE MYELOMA THERAPEUTICS COMPETITION ANALYSIS BY PLAYERS

2.1 Multiple Myeloma Therapeutics Market Size (Value) by Players (2015-2016)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Janssen Biotech, Inc.
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Multiple Myeloma Therapeutics Revenue (Value) (2011-2016)
  3.1.5 Recent Developments
3.2 Bristol-Myers Squibb
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Multiple Myeloma Therapeutics Revenue (Value) (2011-2016)
  3.2.5 Recent Developments
3.3 Novartis AG
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Multiple Myeloma Therapeutics Revenue (Value) (2011-2016)
  3.3.5 Recent Developments
3.4 Bristol-Myers Squibb Company
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Multiple Myeloma Therapeutics Revenue (Value) (2011-2016)
  3.4.5 Recent Developments
3.5 Millennium Pharmaceuticals
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Multiple Myeloma Therapeutics Revenue (Value) (2011-2016)
  3.5.5 Recent Developments
3.6 Celgene Corporation
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Multiple Myeloma Therapeutics Revenue (Value) (2011-2016)
  3.6.5 Recent Developments
3.7 Kesios Therapeutics Limited
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Multiple Myeloma Therapeutics Revenue (Value) (2011-2016)
  3.7.5 Recent Developments
3.8 Amgene, Inc.
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Multiple Myeloma Therapeutics Revenue (Value) (2011-2016)
  3.8.5 Recent Developments
3.9 Genzyme Corporation
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Multiple Myeloma Therapeutics Revenue (Value) (2011-2016)
  3.9.5 Recent Developments
3.10 Juno Therapeutics
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Multiple Myeloma Therapeutics Revenue (Value) (2011-2016)
  3.10.5 Recent Developments

4 GLOBAL MULTIPLE MYELOMA THERAPEUTICS MARKET SIZE BY TYPE AND APPLICATION (2011-2016)

4.1 Global Multiple Myeloma Therapeutics Market Size by Type (2011-2016)
4.2 Global Multiple Myeloma Therapeutics Market Size by Application (2011-2016)
4.3 Potential Application of Multiple Myeloma Therapeutics in Future
4.4 Top Consumer/End Users of Multiple Myeloma Therapeutics

5 UNITED STATES MULTIPLE MYELOMA THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Multiple Myeloma Therapeutics Market Size (2011-2016)
5.2 United States Multiple Myeloma Therapeutics Market Size and Market Share by Players (2015-2016)

6 EU MULTIPLE MYELOMA THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Multiple Myeloma Therapeutics Market Size (2011-2016)
6.2 EU Multiple Myeloma Therapeutics Market Size and Market Share by Players (2015-2016)

7 JAPAN MULTIPLE MYELOMA THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Multiple Myeloma Therapeutics Market Size (2011-2016)
7.2 Japan Multiple Myeloma Therapeutics Market Size and Market Share by Players (2015-2016)

8 CHINA MULTIPLE MYELOMA THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Multiple Myeloma Therapeutics Market Size (2011-2016)
8.2 China Multiple Myeloma Therapeutics Market Size and Market Share by Players (2015-2016)

9 INDIA MULTIPLE MYELOMA THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Multiple Myeloma Therapeutics Market Size (2011-2016)
9.2 India Multiple Myeloma Therapeutics Market Size and Market Share by Players (2015-2016)

10 SOUTHEAST ASIA MULTIPLE MYELOMA THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Multiple Myeloma Therapeutics Market Size (2011-2016)
10.2 Southeast Asia Multiple Myeloma Therapeutics Market Size and Market Share by Players (2015-2016)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2016-2021)

11.1 Global Multiple Myeloma Therapeutics Market Size (Value) by Regions (2016-2021)
  11.1.1 United States Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2021)
  11.1.2 EU Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2021)
  11.1.3 Japan Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2021)
  11.1.4 China Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2021)
  11.1.5 India Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2021)
  11.1.6 Southeast Asia Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2021)
11.2 Global Multiple Myeloma Therapeutics Market Size (Value) by Type (2016-2021)
11.3 Global Multiple Myeloma Therapeutics Market Size by Application (2016-2021)

12 MULTIPLE MYELOMA THERAPEUTICS MARKET DYNAMICS

12.1 Multiple Myeloma Therapeutics Market Opportunities
12.2 Multiple Myeloma Therapeutics Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Multiple Myeloma Therapeutics Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Multiple Myeloma Therapeutics Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Multiple Myeloma Therapeutics Product Scope
Figure Global Multiple Myeloma Therapeutics Market Size (2011-2016)
Table Global Multiple Myeloma Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Figure Global Multiple Myeloma Therapeutics Market Share by Regions in 2015
Figure United States Multiple Myeloma Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Figure EU Multiple Myeloma Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Figure Japan Multiple Myeloma Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Figure China Multiple Myeloma Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Figure India Multiple Myeloma Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Figure Southeast Asia Multiple Myeloma Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Figure Global Multiple Myeloma Therapeutics Market Share by Type in 2015
Figure Chemotherapy And Other Drugs Market Size (Value) and Growth Rate (2011-2016)
Figure Radiation Market Size (Value) and Growth Rate (2011-2016)
Figure Stem Cell Transplant Market Size (Value) and Growth Rate (2011-2016)
Figure Other Supportive Treatments Market Size (Value) and Growth Rate (2011-2016)
Figure Global Multiple Myeloma Therapeutics Market Share by Application in 2015
Figure Multiple Myeloma Therapeutics Market Size and Growth Rate in Hospitals (2011-2016)
Figure Multiple Myeloma Therapeutics Market Size and Growth Rate in Clinics (2011-2016)
Figure Multiple Myeloma Therapeutics Market Size and Growth Rate in Others (2011-2016)
Table Multiple Myeloma Therapeutics Market Size (Value) by Players (2015-2016)
Figure Multiple Myeloma Therapeutics Market Size Share by Players in 2015
Figure Multiple Myeloma Therapeutics Market Size Share by Players in 2016
Table Janssen Biotech, Inc. Basic Information List
Table Multiple Myeloma Therapeutics Business Revenue of Janssen Biotech, Inc. (2011-2016)
Figure Janssen Biotech, Inc. Multiple Myeloma Therapeutics Business Revenue Market Share in 2015
Table Bristol-Myers Squibb Basic Information List
Table Multiple Myeloma Therapeutics Business Revenue of Bristol-Myers Squibb (2011-2016)
Figure Bristol-Myers Squibb Multiple Myeloma Therapeutics Business Revenue Market Share in 2015
Table Novartis AG Basic Information List
Table Multiple Myeloma Therapeutics Business Revenue of Novartis AG (2011-2016)
Figure Novartis AG Multiple Myeloma Therapeutics Business Revenue Market Share in 2015
Table Bristol-Myers Squibb Company Basic Information List
Table Multiple Myeloma Therapeutics Business Revenue of Bristol-Myers Squibb Company (2011-2016)
Figure Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Business Revenue Market Share in 2015
Table Millennium Pharmaceuticals Basic Information List
Table Multiple Myeloma Therapeutics Business Revenue of Millennium Pharmaceuticals (2011-2016)
Figure Millennium Pharmaceuticals Multiple Myeloma Therapeutics Business Revenue Market Share in 2015
Table Celgene Corporation Basic Information List
Table Multiple Myeloma Therapeutics Business Revenue of Celgene Corporation (2011-2016)
Figure Celgene Corporation Multiple Myeloma Therapeutics Business Revenue Market Share in 2015
Table Kesios Therapeutics Limited Basic Information List
Table Multiple Myeloma Therapeutics Business Revenue of Kesios Therapeutics Limited (2011-2016)
Figure Kesios Therapeutics Limited Multiple Myeloma Therapeutics Business Revenue Market Share in 2015
Table Amgene, Inc. Basic Information List
Table Multiple Myeloma Therapeutics Business Revenue of Amgene, Inc. (2011-2016)
Figure Amgene, Inc. Multiple Myeloma Therapeutics Business Revenue Market Share in 2015
Table Genzyme Corporation Basic Information List
Table Multiple Myeloma Therapeutics Business Revenue of Genzyme Corporation (2011-2016)
Figure Genzyme Corporation Multiple Myeloma Therapeutics Business Revenue Market Share in 2015
Table Juno Therapeutics Basic Information List
Table Multiple Myeloma Therapeutics Business Revenue of Juno Therapeutics (2011-2016)
Figure Juno Therapeutics Multiple Myeloma Therapeutics Business Revenue Market Share in 2015
Table Global Multiple Myeloma Therapeutics Market Size by Type (2011-2016)
Figure Global Multiple Myeloma Therapeutics Market Size Share by Type in 2011
Figure Global Multiple Myeloma Therapeutics Market Size Share by Type in 2012
Figure Global Multiple Myeloma Therapeutics Market Size Share by Type in 2013
Figure Global Multiple Myeloma Therapeutics Market Size Share by Type in 2014
Figure Global Multiple Myeloma Therapeutics Market Size Share by Type in 2015
Figure Global Multiple Myeloma Therapeutics Market Size Share by Type in 2016
Table Global Multiple Myeloma Therapeutics Market Size by Application (2011-2016)
Figure Global Multiple Myeloma Therapeutics Market Size by Application in 2011
Figure Global Multiple Myeloma Therapeutics Market Size by Application in 2012
Figure Global Multiple Myeloma Therapeutics Market Size by Application in 2013
Figure Global Multiple Myeloma Therapeutics Market Size by Application in 2014
Figure Global Multiple Myeloma Therapeutics Market Size by Application in 2015
Figure Global Multiple Myeloma Therapeutics Market Size by Application in 2016
Table Top Consumer/End Users of Multiple Myeloma Therapeutics
Figure United States Multiple Myeloma Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Table United States Multiple Myeloma Therapeutics Market Size by Players (2011-2016)
Figure United States Multiple Myeloma Therapeutics Market Size Share by Players in 2015
Figure United States Multiple Myeloma Therapeutics Market Size Share by Players in 2016
Figure EU Multiple Myeloma Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Table EU Multiple Myeloma Therapeutics Market Size by Players (2011-2016)
Figure EU Multiple Myeloma Therapeutics Market Size Share by Players in 2015
Figure EU Multiple Myeloma Therapeutics Market Size Share by Players in 2016
Figure Japan Multiple Myeloma Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Table Japan Multiple Myeloma Therapeutics Market Size by Players (2011-2016)
Figure Japan Multiple Myeloma Therapeutics Market Size Share by Players in 2015
Figure Japan Multiple Myeloma Therapeutics Market Size Share by Players in 2016
Figure China Multiple Myeloma Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Table China Multiple Myeloma Therapeutics Market Size by Players (2011-2016)
Figure China Multiple Myeloma Therapeutics Market Size Share by Players in 2015
Figure China Multiple Myeloma Therapeutics Market Size Share by Players in 2016
Figure India Multiple Myeloma Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Table India Multiple Myeloma Therapeutics Market Size by Players (2011-2016)
Figure India Multiple Myeloma Therapeutics Market Size Share by Players in 2015
Figure India Multiple Myeloma Therapeutics Market Size Share by Players in 2016
Figure Southeast Asia Multiple Myeloma Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Table Southeast Asia Multiple Myeloma Therapeutics Market Size by Players (2011-2016)
Figure Southeast Asia Multiple Myeloma Therapeutics Market Size Share by Players in 2015
Figure Southeast Asia Multiple Myeloma Therapeutics Market Size Share by Players in 2016
Figure Global Multiple Myeloma Therapeutics Market Size (Value) by Regions (2016-2021)
Table Global Multiple Myeloma Therapeutics Market Size by Regions (2016-2021)
Figure Global Multiple Myeloma Therapeutics Market Size Share by Regions in 2017
Figure Global Multiple Myeloma Therapeutics Market Size Share by Regions in 2021
Figure United States Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2021)
Figure EU Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2021)
Figure Japan Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2021)
Figure China Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2021)
Figure India Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2021)
Figure Southeast Asia Multiple Myeloma Therapeutics Revenue and Growth Rate (2016-2021)
Table Global Multiple Myeloma Therapeutics Market Size by Type (2016-2021)
Figure Global Multiple Myeloma Therapeutics Market Size Share by Type in 2017
Figure Global Multiple Myeloma Therapeutics Market Size Share by Type in 2021
Table Global Multiple Myeloma Therapeutics Market Size by Application (2016-2021)
Figure Global Multiple Myeloma Therapeutics Market Size by Application in 2017
Figure Global Multiple Myeloma Therapeutics Market Size by Application in 2021